Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
TCR-1672 by Sino Biopharmaceutical for Asthma: Likelihood of Approval
TCR-1672 is under clinical development by Sino Biopharmaceutical and currently in Phase I for Asthma. According to GlobalData, Phase I...
Data Insights
TCR-1672 by Sino Biopharmaceutical for Endometriosis: Likelihood of Approval
TCR-1672 is under clinical development by Sino Biopharmaceutical and currently in Phase I for Endometriosis. According to GlobalData, Phase I...